Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
Shiitake dermatitis is a condition that commonly occurs in Asian countries and has been recently reported in Europe. We report a case diagnosed after a 16-year history of an intermittent flagellate eruption.
A 45-year-old European man presented with a 16-year history of an intermittent eruption. He described a pruritic outbreak mainly on his trunk, with an associated strange, warm sensation. The eruption lasted approximately 1 week and was not helped by antihistamines. He denied any obvious precipitants and was taking no medication.
On examination, we found grouped, crisscrossed, linear, wheallike lesions, especially over the central back (Figure 1 and Figure 2). He was not dermatographic, and the eruption was not reproducible.
Linear wheallike lesions over the trunk in a flagellate pattern.
More extensive flagellate eruption over the back.
Blood tests revealed eosinophilia during the time that the eruption was present, but findings were normal in between eruptions. All other test results were normal. Further questioning revealed an interest in Asian food and cooking, including shiitake mushrooms. Previous episodes occurred after visits to hotels and restaurants where shiitake mushrooms may have been consumed. The diagnosis of shiitake dermatitis was confirmed with an oral challenge of half-cooked shiitake mushrooms. Thirty-six hours after ingestion of the mushrooms, the patient developed the eruption.
Shiitake dermatitis or toxicoderma is a condition that occurs after the ingestion of raw or half-cooked shiitake mushrooms (Lentinus edodes). First reported in 1977 by Nakamura,1 it is common in Japan and China, but it has recently been reported in England.2 The clinical features are linear groups of pruritic erythematous papules or flagellate dermatitis normally occurring up to 48 hours after mushroom ingestion.
The exact pathogenicity of shiitake flagellate dermatitis is still uncertain. Findings of skinprick and patch testing with mushroom extract are negative; therefore, it is unlikely to be a type I or IV allergy.3 - 4 Interestingly, 44% of patients also have dermatitis of the face, neck, and hands, and a role for a photosensitizing agent has been queried, although this circumstance did not apply to our patient.5 Nakamura3 suggests a form of koebnerization, although the eruption is not reproducible on scratching. It has also been suggested that shiitake dermatitis is caused by a toxic reaction to the polysaccharide lentinan. The beneficial effects of shiitake mushrooms, including reduced blood pressure and lower serum cholesterol levels, are also due to lentinan.3 Hanada and Hashimoto5 postulate that lentinan induces interleukin 1 secretion, which produces vasodilation and thus hemorrhage and eruption.
The eruption is similar to that of bleomycin-induced flagellate dermatitis. The sulfur component has been implicated in pathogenesis. As with shiitake dermatitis, in bleomycin dermatitis, the eruption is not reproduced with scratching despite fresh lesions occurring.6
Our patient did not link his episodic eruption with the eating of shiitake mushrooms owing to the time lag between ingestion and symptoms. Also, the mushrooms did not always cause a reaction; lentinan is thermolabile and can be destroyed with thorough cooking. The popularity of Asian cuisine has increased worldwide, and this case highlights the importance of recognizing an unusual disease, which may occur for many years before presentation.
Correspondence: Dr Garg, Dermatology Department, Royal Hallamshire Hospital, Glossop Road, Sheffield S10 2JF, England (seema.garg@sth.nhs.uk).
Financial Disclosure: None reported.
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal
Instructions
Comments are moderated and will appear on the site at the discretion of the Archives of Dermatology editors. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest* Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 3
Customize your page view by dragging & repositioning the boxes below.
Care at the Close of Life EDUCATION GUIDESPalliative Care for Patients with Head and Neck Cancer
All results at JAMAevidence.com >
and access these and other features:
Register Now
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.